Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …
News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …
News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
News
c_agsandrew_-_fotolia

IBM and Quest forge precision cancer treatment partnership

October 18, 2016 Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
News

Wickham Laboratories Announces Renewal of FDA Accreditation

October 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …
News
Press release
chris_nowers

Kite Pharma appoints Chris Nowers as Head of Europe

October 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma

Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …
Appointment
top_ten_1

Top Ten articles in the pharma industry this week

October 14, 2016 Medical Communications news, october, pharmaceutical, top 10, top ten, top ten stories

This week has seen a lot of news regarding specific drugs going through trial and some impressive results within. Read …
News
regeneron

Regeneron and Ocular Therapeutix to collaborate in potential $315 million deal

October 14, 2016 Medical Communications Bayer, Eyelea, Ocular Therapeutix, Regeneron Pharmaceuticals, wet AMD

Regeneron Pharmaceuticals and Ocular Therapeutix have entered into a deal that will see them collaborate to develop a sustained release …
News

NICE plans new “fast-track” appraisal option

October 14, 2016 Medical Communications, Sales and Marketing NHS, NICE

The National Institute for Health and Care Excellence (NICE) has proposed the introduction of a fast-track process which could make …
News
janssen_latest_logo_on_sign

NICE knocks back Janssen rare disease drug

October 13, 2016 Medical Communications Janssen, NICE, imbruvica

NICE has announced its rejection of Janssen’s Imbruvica (ibrutinib) for the treatment of specific cases of Waldenstrom’s macroglobulinaemia (WM) – …
News
1024px-lyrica

Pfizer loses UK patent infringement case over $5.1bn drug

October 13, 2016 Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, patent infringement, pregabalin

Pfizer has been dealt a significant blow as the UK Court of Appeal has rejected the company’s patent infringement claims …
News
joanna_horobin

Nordic Nanovector announces the appointment of Joanna Horobin as Non-Executive Board Director

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nordic Nanovector, appointment, norway

Nordic Nanovector announced on 12 October that Joanna Horobin was elected to its Board as non-executive director at the company’s …
Appointment

Merck KgaA foresees meeting 2018 objectives and plans for 2022

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, 2022, Germany, Merck KGaA

Speaking at its 2016 Capital Market Day about the progress it had made towards its 2018 objectives, CEO Stefan Oschmann …
News
finance

Sanofi lowers Q3 sales figures from 2015

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results

Sanofi lowered its aggregate sales figure for Q3 2016 from €9.59 billion to €9.46 billion ahead of the release of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025